02616 CSTONE PHARMA-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.60X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 72.2% | Net Margin | N/A |
Total Debt/Equity | 97.8% | Return on Equity | N/A |
Price/Book | 42.81X | Return on Assets | N/A |
(HKD 12.900) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -97.00 | -404.77 | -1,012.08 | -2,348.47 | -1,449.08 |
---|---|---|---|---|---|
Net Profit Growth (%) | +76.0 | +60.0 | +56.9 | -62.1 | +37.3 |
Earnings Per Share (HKD) | -0.076 | -0.321 | -0.863 | -2.016 | -1.385 |
Earnings Per Share Growth (%) | +76.3 | +62.9 | +57.2 | -45.5 | +48.1 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.301 | 0.392 | 0.420 | 1.244 | 2.987 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 49.451 | 254.165 | -80.5 | 261.474 |
Operating Result | -270.183 | 15.359 | -1,859.1 | -209.226 |
Profit Before Taxation | -270.183 | 15.699 | -1,821.0 | -209.226 |
Profit /( Loss) After Taxation | -270.183 | 15.699 | -1,821.0 | -209.226 |
Net Profit | -270.183 | 15.699 | -1,821.0 | -209.226 |
Earnings Per Share () | -0.2253 | 0.0132 | -1,806.8 | -0.1804 |
Announcement Date | 2025-08-14 | 2024-08-23 | NA | 2023-08-15 |
* Annualised
Last Update Time: 2025-09-08 21:40:25